Recon: CDC recommends Pfizer booster for 12- to 15-year-olds; Stryker to buy Vocera for nearly $3B

ReconReconBiologicsBiotechnologyDiagnosticsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy